Sharps Compliance Corp (SMED)
(Delayed Data from NSDQ)
$3.55 USD
+0.18 (5.37%)
Updated May 3, 2019 02:56 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[SMED]
Reports for Purchase
Showing records 81 - 100 ( 100 total )
Industry: Pollution Control
2Q F20; Unused Meds - Route Growth on Track; Pharma Adds a Kicker
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Industry: Pollution Control
Industry: Pollution Control
Industry: Pollution Control
2Q F2020 Preview; Mailback - Unused Medication Remain Focus of Growth
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Industry: Pollution Control
Industry: Pollution Control
1Q F20 Results; Unused Meds - Route Collections Growth Continues
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Industry: Pollution Control
Industry: Pollution Control
Earnings Preview; 1Q F2020 Results Should Set Tone for Year
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Industry: Pollution Control
Industry: Pollution Control
NDR Takeaways - Growth From Route Services - Unused Meds Continue
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Industry: Pollution Control
Industry: Pollution Control
4FQ19; Strong Organic Growth Should Continue; More Margin Leverage Too
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Industry: Pollution Control
Industry: Pollution Control
We initiate coverage with a Buy rating and $4.50 price target
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G